RESULTS OF A RANDOMIZED PHASE III TRIAL OF SEQUENTIAL INTRAVESICAL THERAPY WITH MITOMYCIN C AND BACILLUS CALMETTE-GUERIN VERSUS MITOMYCIN C ALONE IN PATIENTS WITH SUPERFICIAL BLADDER CANCER-Reference-Cited by-同舟云学术

RESULTS OF A RANDOMIZED PHASE III TRIAL OF SEQUENTIAL INTRAVESICAL THERAPY WITH MITOMYCIN C AND BACILLUS CALMETTE-GUERIN VERSUS MITOMYCIN C ALONE IN PATIENTS WITH SUPERFICIAL BLADDER CANCER

Published:1998-11 Issue:5 Volume:160 Page:1668-1672
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

WITJES J.A.¹,CARIS C.T.M.¹,MUNGAN N.A.¹,DEBRUYNE F.M.J.¹,WITJES W.P.J.¹

Affiliation:

1. From the Department of Urology, University Hospital, Nijmegen, The Netherlands

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Long-term results of intravesical therapy for superficial bladder cancer;Lamm;Urol. Clin. N. Amer.,1992

2. A combined analysis of European Organisation for Research and Treatment on Cancer and Medical Research Council clinical trials for the prophylactic treatment of stage TaT1 bladder cancer;Pawinski;J. Urol.,1996

3. Intravesical sequential combination of epirubicin and interferon alpha-2b in patients affected by superficial transitional cell carcinoma of the bladder. Results of a pilot study of Palermo University and proposal of a basic research;Serretta;Prog. Clin. Biol. Res.,1991

4. Alternating mitomycin C and bacillus Calmette-Guerin instillation therapy for carcinoma in situ of the bladder;Rintala;J. Urol.,1995

5. Alternating mitomycin C and bacillus Calmette-Guerin instillation prophylaxis for recurrent papillary (stages Ta to T1) superficial bladder cancer;Rintala;J. Urol.,1996

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analyzing the Systems Biology Effects of COVID-19 mRNA Vaccines to Assess Their Safety and Putative Side Effects;Pathogens;2022-06-29

2. Single immediate instillation of chemotherapy is associated with decreased recurrence and progression in patients with high‐risk non‐muscle‐invasive bladder cancer who receive adjuvant induction bacillus Calmette‐Guérin therapy;International Journal of Urology;2022-05-16

3. Non-muscle-invasive bladder cancer: An overview of potential new treatment options;Urologic Oncology: Seminars and Original Investigations;2021-10

4. Withdrawing from treatment for Bladder cancer: Patient experiences of BCG installations;International Journal of Urological Nursing;2020-06-10

5. Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer;Cochrane Database of Systematic Reviews;2020-01-08